Leonard S. Schleifer, Chief Executive Officer & President, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), sold 15,900 shares at $16.58 ($263K) on 2006-09-13, disclosed to the SEC on 2006-10-18.
Scheduled sale ($263k) by Chief Executive Officer & President, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.50 | 11,007 | $182K | 69.1% |
| 2 | $16.52 | 100 | $2K | 0.6% |
| 3 | $16.55 | 1,500 | $25K | 9.4% |
| 4 | $16.58 | 200 | $3K | 1.3% |
| 5 | $16.61 | 3,093 | $51K | 19.6% |
| Total | $16.53 avg | 15,900 |
| $263K |
| 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |